UK Stomach Cancer Consultants

Professor Justin Stebbing is a Consultant Medical Oncologist based at Imperial College Healthcare NHS Trust in London.

Professor Stebbing trained in medicine at Trinity College Oxford, where he gained a triple first class degree. After completion of junior doctor posts in Oxford, he undertook a residency at The Johns Hopkins Hospital in the US, returning to London to continue his training in oncology at The Royal Marsden and St Bartholomew’s Hospitals. Professor Stebbing’s PhD research investigated the interplay between the immune system and cancer.

Professor Stebbing has published over 500 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing for national newspapers and presenting new data on optimal cancer therapies at major international conferences. His focus is on new therapies in cancer, and the systemic management of patients with a variety of solid malignancies, including a number of new biomarker-based approaches, with an emphasis on circulating tumour cells. His laboratory work is concentrated on new druggable target discovery.

He is a member of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists, and sits on the advisory Boards of five biotechnology companies. He chairs the World Vaccine Congress and is on the editorial board of a number of world leading general medical and cancer journals such as the Journal of Clinical Oncology and Oncogene and writes BMA guidelines for several cancers.

Dr Hendrik-Tobias Arkenau is Medical Director at Sarah Cannon Research UK in London.

Dr Arkenau received his medical and postgraduate degree at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. Before being appointed as, he was Senior Clinical Fellow at the Royal Marsden Hospital and team leader for Early Drug Development at the Prince of Wales Clinical School at the University of New South Wales, Sydney, Australia.

He has obtained ASCO, AACR and ESMO Merit Awards and languages spoken are English and German

Dr David Propper is a Consultant Medical Oncologist based at Barts and The London NHS Trust.

Dr Propper trained in medical oncology at the Imperial Cancer Research Fund Medical Oncology Unit in Oxford and received major trial research experience there. He subsequently spent time at the Lombardi Cancer Centre Georgetown Washington DC, USA.

Dr Propper has interests in translational research, early phase trials and the introduction of new therapeutic agents.

Dr Chris Cottrill is a Consultant Clinical Oncologist based at Barts Cancer Centre (St Bartholomews Hospital) in London.

Dr Cottrill specialises in Breast and Gastrointestinal (oesophagus, stomach, pancreas, colon, rectum and anus) cancers and has a specialist interest in stereotactic radiosurgery (CyberKnife treatment). He has a particular interest in combined modality therapy (combination chemo-radiotherapy). He has been a Consultant at St Bartholomew's Hospital for 10 years and is experienced in all aspects of the chemotherapy and radiotherapy treatment of Breast and Gastrointestinal cancers.

Within the field of radiotherapy Dr Cottrill has a specialist interest in combined chemo-radiotherapy, intensity-modulated radiotherapy (IMRT, RapidArc, VMAT) and image-guided radiotherapy (IGRT). He is fully accredited in the use of CyberKnife stereotactic ablative radiotherapy (SABR) at Barts Hospital, the London Clinic and the Harley Street Clinic CyberKnife units.

Since 2000 Dr Cottrill has lectured annually on international postgraduate courses in the field of evidence-based radiation therapy for the European Society for Radiotherapy and Oncology (ESTRO). 

Dr Sebastian Cummins is a Consultant Clinical Oncologist based at St. Luke's Cancer Centre at The Royal Surrey County Hospital in Guildford.

Dr Cummins specialises in upper and lower gastrointestinal malignancies and hepato-pancreatobiliary (liver and pancreas) malignancy.

He is based at St Lukes' Cancer Centre, from where he is involved in a wide range of research based protocols, both with regards to novel biological therapies and technical radiotherapy development.

Dr Correa is a Consultant Clinical Oncologist based at University Hospitals Coventry and Warwickshire NHS Trust.

Dr Correa specializes in the non-surgical treatment of Gastro-Intestinal cancers with chemotherapy, radiotherapy and targeted biological treatment. He undertook training in Oncology in India at the Tata Memorial Hospital, Bombay. He acquired regional and national post-graduate qualifications in Radiation Oncology. He was awarded the Satya Pal Agarwal Gold Medal for ranking first in India at the national higher specialist examination.

Dr Correa migrated to the United Kingdom in 2003 and initially trained in General Medicine successfully completing the medical membership examination of the Royal College of Physicians. He subsequently trained in Oncology at the Beatson Cancer Centre successfully completing the fellowship examinations of the Royal College of Radiologists.

Dr Correa speaks English and Hindi and is the lead clinician for the non-surgical treatment of colorectal and anal cancers at the Arden Cancer Centre and have commitments to the NHS at University Hospital Coventry and Warwick Hospital.

Dr Correa is a member of the Royal College of Radiologists; Royal College of Physicians and the British Medical Association

Dr Paul Ross is a Consultant Medical Oncologist based at Guy’s & St Thomas’ NHS Foundation Trust, London, where he is Clinical Lead for Chemotherapy and he also consults from King’s College Hospital.  He was appointed Consultant in 2004.

Dr Ross graduated from Guy’s hospital, London after training at the Royal Marsden Hospital and complered a PhD at the institute for cancer research. 

He treats patients with colorectal cancer, oesophago-gastric cancer, pancreatic cancer, malignancies of the bile duct and gall bladder (cholangiocarcinoma) and primary liver cancer (hepatocellular cancer). In addition Dr Ross treats patients with neuroendocrine (carcinoid) tumours. He is focused on treating patients with cancer with chemotherapy and biological therapies. He has an interest in the use of locoregional therapies for liver tumours including SIRT.

Dr Ross is a member of the London Cancer New Drugs, which advises on the introduction of new drugs throughout the London area and their prioritisation.. He is Treasurer of the Association of Cancer Physicians of the United Kingdom. He is also a member of the advanced disease subgroup of the NCRI Colorectal Clinical Studies Group. 

He has been awarded the McElwain Prize, Association of Cancer Physicians in 2002 and previously in 2001 he was awarded the ASCO Merit Award, American Society of Clinical Oncology.

Dr Nick Reed is a Consultant Clinical Oncologist based at Cheltenham General Hospital.

Dr Reed qualified in Southampton and worked as a junior doctor in Winchester, Portsmouth and Cheltenham. Further experience in medicine was gained working in Belize and New Zealand.

He underwent his Oncology training on the Wessex training scheme, working in Southampton, Poole and Portsmouth. Prior to his consultant appointment, he spent one year as a research fellow in Radiation Oncology at the Peter MacCallum Cancer Institute, Melbourne where he furthered his interest in gastro-intestinal radiotherapy.

Dr Reed is a member of the Royal College of Radiologists.

Dr Marcus Wise is a Consultant Clinical Oncologist based at The Rosemere Cancer Centre in Preston.

Dr Wise qualified at Manchester Medical School in 1990.  After training in general medicine and surgery he took up a registrar post in oncology at the Christie Hospital.

He has extensive experience in a wide range of tumour sites involving use of chemotherapy and radiotherapy with a special interest in lower gastrointestinal, urological (including renal carcinoma) and upper gastrointestinal.

He was appointed to a Consultant post at Royal Preston Hospital, Rosemere Cancer Centre, with peripheral clinics at Blackburn and Burnley in 2002. 

Dr Elaine Young is a Consultant Clinical Oncologist based at The Rosemere Cancer Centre at Royal Preston Hospital.

Dr Young qualified from the University of Liverpool in 1988 and gained considerable experience in the field of oncology. She went on to a two year Senior House Officer rotation in general medicine in Liverpool and one year as a Medical Registrar in North Wales. Dr Young first worked in oncology with Trevor Powles at the Royal Marsden Hospital and Undertook Registrar training in clinical oncology at the Christie Hospital in Manchester, before joining the Royal Preston Hospital in 2000 as a Consultant Oncologist, specializing in Breast Cancer, Upper GI Cancer, Chemotherapy & Radiotherapy.

Dr Youngs specialises in Clinical Oncology involving the use of chemotherapy, radiotherapy, endocrine and targeted therapies in the treatment of malignant conditions. She enjoys teaching and is currently involved in the development of undergraduates and postgraduates.

She was Awarded the Henry Briggs memorial medal, in 1998 and the Red Rose Hero award, in 2007.